aTYR PHARMA INC (ATYR)
Biological Products, (No Diagnostic Substances)
Latest Price
$0.49
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.59
P/B Ratio
0.82
Institutional Ownership
56.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 14.71M | $11.0M | 15.00% | +8.8K | 2026-03-31 |
| FEDERATED HERMES, INC. | 10.51M | $8.0M | 10.72% | -- | 2026-03-31 |
| BlackRock, Inc. | 6.44M | $5.0M | 6.57% | -105.8K | 2026-03-31 |
| UBS Group AG | 3.87M | $3.0M | 3.94% | +2.24M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.81M | $2.0M | 3.89% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.39M | $1.0M | 2.43% | +101.8K | 2026-03-31 |
| STATE STREET CORP | 1.75M | $1.0M | 1.79% | +29.6K | 2026-03-31 |
| GSA CAPITAL PARTNERS LLP | 1.68M | $1.0M | 1.72% | -946.1K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1.64M | $1.0M | 1.67% | -249.7K | 2026-03-31 |
| MORGAN STANLEY | 1.23M | -- | 1.25% | -177.5K | 2026-03-31 |